There is a fundamental gap in understanding how diabetes impacts the retinal neurons that provide vision. Because of this, current therapies intervene in latter stages of the disease, when blood vessels are affected. Anti-VEGF therapy limits damage in advanced diabetic retinopathy (DR), but does not address damage to the neurosensory retina. Hence, the long-term goal of this project is to define the mechanisms that cause retinal ganglion cell (RGC) dysfunction in patients with DR. The overall objective is to define the roles of mechanistic target of rapamycin complex 2 (mTORC2) signaling in the interactions between hyperglycemia and protein synthesis that lead to RGC dysfunction and subsequent vision loss in DR. The project will utilize diabetic rats and mice, which are the standard pre-clinical models of DR, and which exhibit the early neurodegenerative changes of human DR. The central hypothesis is that diabetes-induced defects in mTORC2 signaling impair protein synthesis, axonal function and survival of retinal ganglion cells. The rationale for this work is that identifying pathways causing RGC dysfunction and death will ultimately lead to preventive treatments and better vision for persons with diabetes. The hypothesis is supported by strong preliminary data showing: 1) prominent mTOR and Rictor expression in RGCs; 2) reduced mTOR expression in diabetic human donor eyes; and 3) the ability to conditionally knockout of Rictor expression in adult mice. The hypothesis will be tested in two specific aims: 1) to define the mechanisms by which diabetes impairs retinal mTORC2 activity and the cell-specific effects of diabetes on protein synthesis, and 2) to define the consequences of impaired mTORC2 activity on retinal ganglion cell protein synthesis, survival and morphology.
The first aim will examine the effect of diabetes on mTORC2 complex member protein expression in human retinas, use diabetic rodent models to determine the molecular mechanisms by which diabetes reduces retinal mTORC2 activity and protein synthesis, and examine the cell-specificity of these effects.
The second aim will employ in vivo spatial and cell- specific targete loss-of-function studies to disrupt mTORC complexes by knockout of the mTOR-associated proteins Rictor and Raptor in inner retinal neurons and determine the effects on protein turnover, axonal function and cell survival. The proposal is innovative because it: 1) expands the novel observation of diminished mTORC2 activity in DR and investigates the unexplored area of mTOR function in the neural retina; 2) will be the first to examine the cell-specific alterations i retinal mTORC complexes and protein synthesis leading to loss of neuronal integrity in DR; and 3) will use innovative techniques, including translatomics to define cell-specific changes in retinal mRNA translation, and targeted AAV-cre recombinase vectors to delete Rictor, Raptor and protein phosphatase PP2A genes in RGC. The work is significant because it will elucidate clinically relevant means to restore defective signaling pathways responsible for loss of RGC function in retinal diseases that have universal importance to vision and implications for the NEI Audacious Goals Initiatives.

Public Health Relevance

The proposed research is relevant to public health because it will identify pathways causing retinal neuron dysfunction and death and will ultimately lead to preventive treatments and better vision for persons with diabetes. Thus, the proposed research is relevant to the part of NIH's mission that pertains to developing fundamental knowledge that will help to reduce the burdens of human disability.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY020582-09
Application #
9547435
Study Section
Diseases and Pathophysiology of the Visual System Study Section (DPVS)
Program Officer
Shen, Grace L
Project Start
2010-05-01
Project End
2019-08-31
Budget Start
2018-09-01
Budget End
2019-08-31
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Rajala, Ammaji; Wang, Yuhong; Abcouwer, Steven F et al. (2018) Developmental and light regulation of tumor suppressor protein PP2A in the retina. Oncotarget 9:1505-1523
Sundstrom, Jeffrey M; Hernández, Cristina; Weber, Sarah R et al. (2018) Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases. Invest Ophthalmol Vis Sci 59:2264-2274
Abramoff, Michael D; Fort, Patrice E; Han, Ian C et al. (2018) Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease. Invest Ophthalmol Vis Sci 59:519-527
Kiang, Lee; Ross, Bing X; Yao, Jingyu et al. (2018) Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal Detachment. Invest Ophthalmol Vis Sci 59:3767-3778
Simó, Rafael; Stitt, Alan W; Gardner, Thomas W (2018) Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia 61:1902-1912
Shah, Anjali R; Gardner, Thomas W (2017) Diabetic retinopathy: research to clinical practice. Clin Diabetes Endocrinol 3:9
Wang, Sophia Y; Andrews, Chris A; Herman, William H et al. (2017) Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States. Ophthalmology 124:424-430
Gardner, Thomas W; Sundstrom, Jeffrey M (2017) A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping. Vision Res 139:153-160
Wang, Sophia Y; Andrews, Chris A; Gardner, Thomas W et al. (2017) Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network. JAMA Ophthalmol 135:432-438
Gardner, Thomas W; Davila, Jose R (2017) The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 255:1-6

Showing the most recent 10 out of 40 publications